Investigations on the Influence of Bariatric Surgery on the Metabolism and Absorption of Atorvastatin
NCT00331565 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 36
Last updated 2014-12-03
Summary
Altered bioavailability of drugs will potentially affect both drug efficacy as well as safety. In patients subjected to bariatric surgery due to morbid obesity the gastro intestinal tract is considerably reconstructed and a change in drug bioavailability is very likely. Getting further knowledge on important mechanisms responsible for altered bioavailability would help in predicting clinically relevant consequences on different drugs.
In the present study we aim to investigate the effect of bariatric surgery on atorvastatin bioavailability. Atorvastatin is subjected to both extensive metabolism and drug transport and will potentially be a good predictor for mechanisms relevant for other drugs as well.
In addition will the expression of different enzymes and transporters be measured in the gastrointestinal tract and in the liver to elucidate on mechanism behind the eventual effects.
Conditions
- Morbid Obesity
Interventions
- PROCEDURE
-
Bariatric surgery
Gastric bypass, duodenal switch and sleeve surgery
Sponsors & Collaborators
-
The Hospital of Vestfold
collaborator OTHER -
University of Oslo School of Pharmacy
lead OTHER
Principal Investigators
-
Rune Sandbu, MD, PhD · Hospital in Vestfold
Study Design
- Allocation
- NON_RANDOMIZED
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-08-31
- Primary Completion
- 2010-12-31
- Completion
- 2010-12-31
Countries
- Norway
Study Locations
More Related Trials
-
Acute Effect of HMG-CoA Reductase Inhibition (Atorvastatin)on Renal Hemodynamics, Tubular Function and Vasoactive Hormones on Healthy Subjects
NCT00344955 ·Status: COMPLETED ·Phase: PHASE4
-
Cardiopulmonary-bypass and Reno-protective Effect of Atorvastatin Trial
NCT00910221 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Atorvastatin Versus Simvastatin In The Prevention Of Coronary Heart Disease (CHD) In Patients With Known CHD
NCT00159835 ·Status: COMPLETED ·Phase: PHASE4
-
Bioavailability Study for New Atorvastatin Formulation
NCT00844376 ·Status: COMPLETED ·Phase: PHASE4
-
Pharmacokinetic And Pharmacodynamic Study Of A Single-Dose Of PF-04950615 (RN316) In Combination With Atorvastatin
NCT01163851 ·Status: COMPLETED ·Phase: PHASE1
-
Atorvastatin in Moderate Active Crohns Disease
NCT00454545 ·Status: COMPLETED ·Phase: PHASE2
-
Phase I Drug-drug Interaction of Omega-3 and Atorvastatin
NCT03438955 ·Status: UNKNOWN ·Phase: PHASE1
-
Combined Effects of Statins and Exercise on Training Sensitive Health Markers
NCT06841536 ·Status: COMPLETED ·Phase: NA
-
Association Between Systemic Exposure of Atorvastatin and Metabolites and Atorvastatin-induced Myotoxicity
NCT00120055 ·Status: COMPLETED ·Phase: PHASE4
-
Differences in Atorvastatin Metabolite Ratios as a Diagnostic Tool in Detecting Atorvastatin Induced Myotoxicity
NCT00199745 ·Status: COMPLETED ·Phase: PHASE4
-
Pleiotropic Effects of Atorvastatin in High Cardiovascular Risk Patients
NCT01013103 ·Status: COMPLETED ·Phase: PHASE4
-
Prothrombotic Inflammatory Markers in Women With Metabolic Syndrome - Effect of Atorvastatin
NCT01785615 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effect of Lipid Modifying Drugs on HDL Function in Patients With Hyperlipidemia
NCT02942602 ·Status: COMPLETED ·Phase: NA
-
Carotid Atorvastatin Study in Hyperlipidemic Post-Menopausal Women
NCT00163163 ·Status: COMPLETED ·Phase: PHASE3
-
Canadians Achieve Cholesterol Targets Fast With Atorvastatin Stratified Titration
NCT00150371 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Of Atorvastatin For The Treatment Of High Cholesterol In Patients At High Risk Of Coronary Heart Disease (CHD)
NCT00644709 ·Status: COMPLETED ·Phase: PHASE4
-
Drug Interaction Study - Assess Pharmacokinetics of Both AZD5672 and Atorvastatin
NCT00722956 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Effect of Atorvastatin on the Pharmacokinetics of Fimasartan in Healthy Male Volunteers
NCT00991705 ·Status: COMPLETED ·Phase: PHASE1
-
Use of Atorvastatin (Lipitor) to Decrease Panel Reactive Antibody Titers
NCT00143741 ·Status: COMPLETED ·Phase: PHASE1
-
The Efficacy and Tolerability of Two Formulations of Atorvastatin In Korean Adult With Hypercholesterolemia
NCT01285544 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Atorvastatin Treatment on Carotid Plaque.
NCT00343655 ·Status: TERMINATED ·Phase: PHASE3
-
The Pleiotropic Effects of Atorvastatin When Combined With Common Antihypertenisve Medications.
NCT00656331 ·Status: WITHDRAWN ·Phase: NA
-
A Study Of The Efficacy Of Atorvastatin For Lowering Cholesterol In High-Risk Patients With High Cholesterol
NCT00644670 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Investigate the Effect of Telmisartan/S-amlodipine on the Pharmacokinetic Properties of Atorvastatin.
NCT01842256 ·Status: COMPLETED ·Phase: PHASE1
-
Study To Evaluate The Effect Of Torcetrapib/Atorvastatin In Patients With Genetic High Cholesterol Disorder
NCT00134511 ·Status: COMPLETED ·Phase: PHASE3